NCCN 2012 Webinar Series: Sarcomas™: Bone Cancers: Management of Relapsed or Refractory Disease

November 29, 2012

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone). Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this webinar, participants should be able to:

  • Discuss the current treatment options for patients with relapsed or refractory bone cancers
  • Describe the limitations of the treatment and the need for the development of more effective treatment options
  • Review the mechanism of action of targeted therapies that are being evaluated in clinical trials
Additional information

This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, and ZIOPHARM Oncology, Inc.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
Course expires: 
Event starts: 
11/29/2012 - 2:30pm EST
Event ends: 
11/29/2012 - 3:30pm EST

James E. Butrynski, MD
Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician


Please login or register to take this course.